Rare Case of Classic Hodgkin Lymphoma in a Patient with Ulcerative Colitis

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2024 Dec 11

PMID 39663134

Authors

Nicole Allyson Chua

Jose Sollano Jr

Affiliations

Soon will be listed here.

Abstract

Primary gastrointestinal tract lymphoma (PGIL) is a rare form of presentation of gastrointestinal tract (GI) lymphomas. Inflammatory bowel disease (IBD) and the use of thiopurines are known risk factors for its appearance. We report a male patient in his early 70s treated only with mesalamine for ulcerative colitis (UC) for the past 6 years. He was admitted due to COVID-19 and anaemia secondary to massive haematochezia. The patient underwent total colectomy with end ileostomy, with intraoperative proctoscopy. Tissue biopsy demonstrated typical features of UC; however, atypical lymphoid proliferation of the regional lymph nodes with histological and immunochemical staining results was suggestive of classic Hodgkin lymphoma, nodular sclerosis subtype. The patient was treated with adriamycin, vinblastine and dacarbazine chemotherapy initially successful after 1 session but later opted for palliative care. Due to its rarity, lymphoid neoplasms occurring in the context of IBD are poorly known.

References

Beaugerie L, Brousse N, Bouvier A, Colombel J, Lemann M, Cosnes J . Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009; 374(9701):1617-25. DOI: 10.1016/S0140-6736(09)61302-7. View

Papaxoinis G, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Pavlidis N . Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006; 47(10):2140-6. DOI: 10.1080/10428190600709226. View

Wang R, Li Z, Liu S, Zhang D . Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023; 13(3):e065186. PMC: 10069527. DOI: 10.1136/bmjopen-2022-065186. View

Muller M, Broseus J, Feugier P, Thieblemont C, Beaugerie L, Danese S . Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis. 2020; 15(5):827-839. DOI: 10.1093/ecco-jcc/jjaa193. View

Koch P, Probst A, Berdel W, Willich N, Reinartz G, Brockmann J . Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005; 23(28):7050-9. DOI: 10.1200/JCO.2005.04.031. View

Gurney K, Cartwright R . Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J. 2002; 3(2):95-104. DOI: 10.1038/sj.thj.6200154. View

Thayu M, Markowitz J, Mamula P, Russo P, Muinos W, Baldassano R . Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease. J Pediatr Gastroenterol Nutr. 2005; 40(2):220-2. DOI: 10.1097/00005176-200502000-00026. View

DiSanti W, Rajapakse R, Korelitz B, Panagopoulos G, Bratcher J . Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006; 4(8):1025-9. DOI: 10.1016/j.cgh.2006.03.018. View

Ghimire P, Wu G, Zhu L . Primary gastrointestinal lymphoma. World J Gastroenterol. 2011; 17(6):697-707. PMC: 3042647. DOI: 10.3748/wjg.v17.i6.697. View

10.

Russo M, Diddoro A, Iodice A, Severi C, Castagneto-Gissey L, Casella G . Incidence of lymphomas in inflammatory bowel disease: report of an emblematic case, systematic review, and meta-analysis. Front Med (Lausanne). 2023; 10:1172634. PMC: 10188968. DOI: 10.3389/fmed.2023.1172634. View

11.

Tevlin R, Larkin J, Hyland J, OConnell P, Winter D . Primary colorectal lymphoma - A single centre experience. Surgeon. 2014; 13(3):151-5. DOI: 10.1016/j.surge.2014.01.002. View

12.

Lewis J, Deren J, Lichtenstein G . Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 1999; 28(2):459-77, x. DOI: 10.1016/s0889-8553(05)70065-0. View

13.

Khuroo M . Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. BMJ Case Rep. 2014; 2014. PMC: 4039912. DOI: 10.1136/bcr-2013-203354. View

14.

Xue X, Cao Z, Yuan T, Luo Y, Mu J, Qin Y . [Pathological characteristics and clinical prognosis of nodular sclerosis grade 2 of classic Hodgkin's lymphoma]. Zhonghua Zhong Liu Za Zhi. 2022; 44(6):581-586. DOI: 10.3760/cma.j.cn112152-20210302-00190. View

15.

Olen O, Smedby K, Erichsen R, Pedersen L, Halfvarson J, Hallqvist-Everhov A . Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clin Gastroenterol Hepatol. 2023; 21(12):3132-3142. DOI: 10.1016/j.cgh.2023.04.001. View

16.

Park S . Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?. Intest Res. 2022; 20(2):159-164. PMC: 9081986. DOI: 10.5217/ir.2021.00115. View

17.

Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F . Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006; 54(3):692-701. DOI: 10.1002/art.21675. View

18.

Cai S, Cannizzo Jr F, Dunn K, Gibbs J, Czuczman M, Rajput A . The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum. Am J Surg. 2007; 193(3):409-12. DOI: 10.1016/j.amjsurg.2006.12.007. View

19.

Kandiel A, Fraser A, Korelitz B, Brensinger C, Lewis J . Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005; 54(8):1121-5. PMC: 1774897. DOI: 10.1136/gut.2004.049460. View

20.

Kotlyar D, Lewis J, Beaugerie L, Tierney A, Brensinger C, Gisbert J . Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2014; 13(5):847-58.e4. DOI: 10.1016/j.cgh.2014.05.015. View